CitedEvidenceResearch APIs

Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

article · 1995

Oral high-dose medroxyprogesterone acetate treatment for recurrent breast cancer.

Oral high-dose medroxyprogesterone acetate (MPA) treatment (600, 800, 1200 mg/day or changed dosage) was given to 49 patients with recurrent breast cancer fr...

5 citations
Oral high-dose medroxyprogesterone acetate treatment for recurrent breast cancer.